Vitamin D in HIV-Infected Patients on HAART

Completed · Not applicable

Conditions studied: Vitamin D Deficiency, HIV

In brief

This is a research study to look at vitamin D deficiency (low levels) in men and women with HIV. As part of your regular medical care, you will be screened for vitamin D deficiency. If your levels are low, and you choose to start using vitamin D supplements, the investigators would like to take some blood before and after you start using vitamin D to see how this affects your levels of HIV, T cells, cholesterol, and other blood levels. The investigators will provide you with vitamin D supplements for the first 24 weeks (6 months) of the study. If you and your physician decide that you should continue taking vitamin D supplements after that time, you will be responsible for purchasing your own vitamin D supplements.

Key facts

Study ID

NCT01250899

Run by

University of California, Los Angeles

People needed

122

Starts

2010-10-01

Expected to finish

2012-06-01

Last updated by the study team

2014-11-25

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-positive men and women age 18 and older.
• HIV-1 RNA documented to be < 200 copies/mL on their current ART regimen, with supporting viral load documentation in the 24 weeks prior to study entry.
• Subjects must receive primary HIV care at the UCLA CARE center.
• Subjects must be undergoing screening for vitamin D deficiency by their primary care provider at the time of study entry, or have undergone vitamin D screening in the 90 days prior to consent without yet initiating vitamin D supplementation (for insufficient subjects).
• Ability and willingness of subject to provide informed consent

You may not qualify if…

• Use of vitamin D supplementation (not including 400 IU daily, the amount in a standard multivitamin) at the time of screening.
• HIV-infected subjects not on ART.
• HIV-infected subjects not suppressed on their current ART regimen (HIV-1 RNA > 200 copies/mL in the 6 months prior to screening).

Where it is running

• UCLA CARE Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.